Peter Orth

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Protein Technologies (United Kingdom)

Biochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy”.

Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

Nature Communications(2025)10.1038/s41467-025-58431-z

N/A

0DataRank · unranked

19 citations

Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern +14 more